Marrone Bio Innovations (Marrone Bio Innovations) Days Payable : 56.40 (As of Mar. 2022)

View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations Days Payable?

Marrone Bio Innovations's average Accounts Payable for the three months ended in Mar. 2022 was $3.02 Mil. Marrone Bio Innovations's Cost of Goods Sold for the three months ended in Mar. 2022 was $4.89 Mil. Hence, Marrone Bio Innovations's Days Payable for the three months ended in Mar. 2022 was 56.40.

The historical rank and industry rank for Marrone Bio Innovations's Days Payable or its related term are showing as below:

MBII' s Days Payable Range Over the Past 10 Years
Min: 49 Med: 90.89 Max: 199.19
Current: 53.13

During the past 11 years, Marrone Bio Innovations's highest Days Payable was 199.19. The lowest was 49.00. And the median was 90.89.

MBII's Days Payable is not ranked
in the Agriculture industry.
Industry Median: 78.58 vs MBII: 53.13

Marrone Bio Innovations's Days Payable increased from Mar. 2021 (45.80) to Mar. 2022 (56.40). It may suggest that Marrone Bio Innovations delayed paying its suppliers.

Marrone Bio Innovations Days Payable Historical Data

The historical data trend for Marrone Bio Innovations's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marrone Bio Innovations Days Payable Chart

Marrone Bio Innovations Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Payable

Get a 7-Day Free Trial

89.88

91.89

69.79

62.08

49.00

Marrone Bio Innovations Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Days Payable	Get a 7-Day Free Trial															45.80	37.30	57.31	59.78	56.40

Competitive Comparison of Marrone Bio Innovations's Days Payable

For the Agricultural Inputs subindustry, Marrone Bio Innovations's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marrone Bio Innovations's Days Payable Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Marrone Bio Innovations's Days Payable distribution charts can be found below:

* The bar in red indicates where Marrone Bio Innovations's Days Payable falls into.

Marrone Bio Innovations Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Marrone Bio Innovations's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (1.895	+	2.687)	/	2 )	/	17.064	*	365
=	2.291					/	17.064	*	365
=	49.00

Marrone Bio Innovations's Days Payable for the quarter that ended in Mar. 2022 is calculated as:

	Days Payable (Q: Mar. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2021 )	+	Accounts Payable (Q: Mar. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2022 )	*	Days in Period
=	( (2.687	+	3.359)	/	2 )	/	4.891	*	365 / 4
=	3.023					/	4.891	*	365 / 4
=	56.40

Marrone Bio Innovations Days Payable Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617

Website

https://www.marronebioinnovations.com

Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.

Executives

Pamela G Marrone	director, officer: CEO and President	C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson	officer: Interim CFO	C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p.	other: See Footnote (1)	262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung	officer: Chief Financial Officer	C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen	officer: SVP, International Sales	C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee	director	C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash	director, officer: Chief Executive Officer	C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc	other: See Footnotes(1)(2)	262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc	director, 10 percent owner, other: (See Remarks)	437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc.	director, 10 percent owner, other: (See Remarks)	320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p.	director, 10 percent owner, other: (See Remarks)	320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson	director, 10 percent owner, other: (See Remarks)	C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p.	other: See Footnote (1)	C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc	director, 10 percent owner, other: (See Remarks)	C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v.	10 percent owner	LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME